HEAL General Assembly 2022
For the first time since 2019, HEAL members came together in person in Brussels again, for the HEAL Annual General Assembly in October 2022. The HEAL secretariat and members spent…
For the first time since 2019, HEAL members came together in person in Brussels again, for the HEAL Annual General Assembly in October 2022. The HEAL secretariat and members spent…
PFHpA, a member of the hazardous PFAS family, is increasingly being found in our bodies and the environment. HEAL supports the Dutch proposal to identify PFHpA as a substance of very high concern under REACH, which would constitute the first step to put an end to our exposure to this toxic chemical. However, all PFAS need to be regulated as a group to truly get at the root of the problem to prevent further harm.
6 December 2022, 16:00 - 16:45 CEST Click here to watch the recording of the webinar Click here to download the presentation slides Pregnant women are ubiquitously exposed to a…
More than 115 scientists have asked the World Health Organization for a complete overhaul or withdrawal of the organisation’s draft drinking water guidelines for two of the most well-studied per- and polyfluoroalkyl substances (PFAS), namely PFOS and PFOA.
Melamine's potential irreversible impacts on health and the environment warrant regulatory action now. Here are 6 things you need to know about this harmful chemical (and why we support Germany's proposal to identify it as a substance of very high concern).
46 European civil society organisations urgently demand EU member states and the Commission to ban all PFAS in consumer products by 2025 and across all uses by 2030.
The EDC-Free Europe coalition, of which HEAL is a member, has welcomed the publication of the European Commission’s draft proposal for new hazard classes for the identification of endocrine disrupting chemicals (EDCs) in the CLP regulation.
In July this year, the hazard classification of three lithium salts was discussed in a meeting of the CARACAL expert group, which brings together representatives from EU member states, the European Commission and stakeholders. Shockingly, industry representatives used this meeting to bring up misplaced arguments in opposition to the proposed classification, including socio-economic considerations which have no place in scientific discussions about hazard classifications.
To raise awareness about the presence of hazardous substances in food contact materials and why we need more protective regulations to address them, HEAL has teamed up with Zero Waste Europe and CHEM Trust to launch a new website on toxic-free food packaging.
HEAL’s new infographic illustrates how the upcoming revision of the EU Classification, Labelling and Packaging (CLP) Regulation can help better identify harmful endocrine disrupting chemicals (EDCs) within European chemicals laws.
HEAL has joined 24 civil society organisations to call on the European Commission to publish the EU Nature Package on the planned date to tackle the climate, health and biodiversity crises.
To mark the start of the European Week Against Cancer 2022, the Health and Environment Alliance (HEAL) and the European Cancer Leagues (ECL) have teamed up to relaunch an infographic telling the story behind environmental cancer prevention.
The EU Commission's Chemicals Restriction Roadmap is a turning point in the European regulatory approach to harmful chemicals. But important details for turning the plan into a regulatory reality are missing, health groups point out.
This easy-to-use infographic explains why reforming EU rules on the Classification, Labelling and Packaging of chemicals (CLP) is an opportunity to better protect health in the European Union.
The Health Environment Research Agenda for Europe (HERA), of which HEAL is a project partner, will hold its final conference on 18 March 2022, taking place in Paris and as…
Health groups have welcomed Belgium’s first-ever draft national action plan on endocrine disrupting chemicals (EDCs) as an important step towards better identification of and health protection against the risks associated to exposure to such harmful substances.
Join us for a special webinar on February 23rd to explore how prenatal and postnatal exposure to PFAS affects child cardiometabolic health and inflammatory biomarkers.